Acoltremon is an ophthalmic TRPM8 receptor agonist indicated for the treatment of dry eye disease by stimulating tear production. This category provides essential materials for the analytical evaluation… Read more





Acoltremon is an ophthalmic TRPM8 receptor agonist indicated for the treatment of dry eye disease by stimulating tear production. This category provides essential materials for the analytical evaluation of this therapeutic agent, including the active pharmaceutical ingredient, associated diastereomers, and various structural impurities. Laboratories utilize these high-quality reference standards for rigorous impurity profiling and method validation during pharmaceutical development and quality control. By incorporating specific hydroxy and methoxy derivatives, as well as stable isotope labelled compounds, analytical scientists can accurately identify, quantify, and monitor degradation products or metabolic pathways. Access to these characterized reference materials ensures compliance with regulatory standards and supports the ongoing pharmacological assessment of this specific TRPM8-targeting compound throughout its production lifecycle.